Flavoxate Hydrochloride

盐酸黄酮哌酯

Report date: 2023/02/27 09:47:24
NME

Base Information

Drug NameFlavoxate Hydrochloride
Drug Alias Nameflavoxato黄酮哌酯盐酸盐flavoxate盐酸黄酮呱酯flavoxatum +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium release-activated calcium channel protein 1 blockers
TargetsCalcium release-activated calcium channel protein 1
Therapy Area/IndicationsDysuriaPainUrinary Incontinence, Urge +[5] 
Global Approved IndicationsDysuriaPainUrinary Incontinence, Urge +[5] 
Approved Indications in ChinaDysuriaPainUrinary Incontinence, Urge +[5] 
Original Approved Country/TerritoryUnited States
Original Approved Date1970/01/15
Country/TerritoryUnited StatesUnited KingdomMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesRecordati Pharmaceuticals LtdWuxi No 7 Pharmaceutical Co LtdNippon Shinyaku Co Ltd
Inactive CompaniesOrtho-Mcneil-Janssen Pharmaceuticals IncPadagis LLC
Active IndicationsDysuriaPainUrinary Incontinence, Urge +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeG04BD02
Related LinksWikipediaDrugBankKEGG